{"query-id": "1", "query-text": "melanoma BRAF (V600E) 64-year-old male", "response": "BRAF mutation in melanoma 64-year-old male", "metadata": {"model": "llama"}}
{"query-id": "2", "query-text": "melanoma BRAF (V600K) 54-year-old male", "response": "BRAF(V600K) mutation in melanoma, prognosis for 50-year-old male patient.", "metadata": {"model": "llama"}}
{"query-id": "3", "query-text": "melanoma BRAF (V600R) 80-year-old male", "response": "Treatment options for metastatic melanoma in an 80-year-old male.", "metadata": {"model": "llama"}}
{"query-id": "4", "query-text": "melanoma BRAF (K601E) 38-year-old male", "response": "How is melanoma BRAF mutation treated in a 38-year-old male?", "metadata": {"model": "llama"}}
{"query-id": "5", "query-text": "melanoma BRAF (V600E), PTEN loss of function 57-year-old male", "response": "Potential treatment options for melanoma in a 57-year-old male with BRAF (V600E) mutation and PTEN loss of function.", "metadata": {"model": "llama"}}
{"query-id": "6", "query-text": "melanoma BRAF (V600E), NRAS (Q61R) 67-year-old male", "response": "Best treatment options for melanoma BRAF V600E and NRAS Q61R in a 67-year-old male patient.", "metadata": {"model": "llama"}}
{"query-id": "7", "query-text": "melanoma BRAF amplification 61-year-old male", "response": "Braf amplification in melanoma diagnostic testing 61-year-old male.", "metadata": {"model": "llama"}}
{"query-id": "8", "query-text": "melanoma NRAS (Q61R) 63-year-old female", "response": "What are the treatment options for NRAS-mutated melanoma in a 63-year-old female patient?", "metadata": {"model": "llama"}}
{"query-id": "9", "query-text": "melanoma NRAS (Q61L) 34-year-old female", "response": "Information on melanoma NRAS mutation (Q61L) in a 34-year-old female.", "metadata": {"model": "llama"}}
{"query-id": "10", "query-text": "melanoma KIT (L576P) 65-year-old female", "response": "Stage 3 melanoma treatment options 65-year-old female", "metadata": {"model": "llama"}}
{"query-id": "11", "query-text": "melanoma KIT (L576P), KIT amplification 56-year-old female", "response": "Information on KIT amplification in melanoma, specifically in a 56-year-old female patient with KIT (L576P) mutation.", "metadata": {"model": "llama"}}
{"query-id": "12", "query-text": "melanoma KIT (K642E) 62-year-old female", "response": "Melanoma diagnosis K642E 62-year-old female treatment options", "metadata": {"model": "llama"}}
{"query-id": "13", "query-text": "melanoma KIT (N822Y) 39-year-old female", "response": "Treatment options for melanoma in a 39-year-old female with the N822Y mutation.", "metadata": {"model": "llama"}}
{"query-id": "14", "query-text": "melanoma KIT amplification 66-year-old female", "response": "Treatment options for melanoma in a 66-year-old female with KIT amplification", "metadata": {"model": "llama"}}
{"query-id": "15", "query-text": "melanoma NF1 truncation 70-year-old male", "response": "Best treatments for melanoma in elderly patients with NF1 mutation", "metadata": {"model": "llama"}}
{"query-id": "16", "query-text": "melanoma NTRK1 rearrangement 60-year-old male", "response": "Testing for NTRK1 gene rearrangement in melanoma, a 60-year-old male.", "metadata": {"model": "llama"}}
{"query-id": "17", "query-text": "melanoma TP53 loss of function 72-year-old male", "response": "72-year-old male with melanoma and TP53 mutation", "metadata": {"model": "llama"}}
{"query-id": "18", "query-text": "melanoma tumor cells with >50% membranous PD-L1 expression 48-year-old female", "response": "Cancer treatments for melanoma with high PD-L1 expression.", "metadata": {"model": "llama"}}
{"query-id": "19", "query-text": "melanoma tumor cells negative for PD-L1 expression 73-year-old male", "response": "Treatment options for melanoma in elderly patients", "metadata": {"model": "llama"}}
{"query-id": "20", "query-text": "melanoma high tumor mutational burden 86-year-old female", "response": "Does high TMB predict poor prognosis in melanoma patients over 75?", "metadata": {"model": "llama"}}
{"query-id": "21", "query-text": "melanoma extensive tumor infiltrating lymphocytes 49-year-old male", "response": "Significance of tumor-infiltrating lymphocytes in melanoma: A 49-year-old male patient with extensive tumor-infiltrating lymphocytes in their melanoma may have a better prognosis compared to those without such infiltration. Research suggests that the presence of these immune cells within the tumor can decrease the risk of disease recurrence and improve overall survival.", "metadata": {"model": "llama"}}
{"query-id": "22", "query-text": "melanoma no tumor infiltrating lymphocytes 74-year-old female", "response": "Treatment options for advanced melanoma in elderly patients?", "metadata": {"model": "llama"}}
{"query-id": "23", "query-text": "melanoma PTEN loss of function 68-year-old male", "response": "Symptoms of PTEN mutation in melanoma patients.", "metadata": {"model": "llama"}}
{"query-id": "24", "query-text": "melanoma APC loss of function 47-year-old male", "response": "Can APC gene mutation cause melanoma in a 47-year-old male?", "metadata": {"model": "llama"}}
{"query-id": "25", "query-text": "melanoma high serum LDH levels 69-year-old female", "response": "Can LDH levels indicate melanoma in a 69-year-old female?", "metadata": {"model": "llama"}}
{"query-id": "26", "query-text": "colorectal cancer NRAS 49-year-old male", "response": "Colorectal cancer treatment options for a 49-year-old male with NRAS mutation.", "metadata": {"model": "llama"}}
{"query-id": "27", "query-text": "medullary thyroid carcinoma RET 45-year-old female", "response": "Information on medullary thyroid carcinoma (MTC) in 45-year-old females, including symptoms, diagnosis, treatment options, and prognosis.", "metadata": {"model": "llama"}}
{"query-id": "28", "query-text": "neuroblastoma ALK 4-year-old female", "response": "Treatment options for neuroblastoma in children.", "metadata": {"model": "llama"}}
{"query-id": "29", "query-text": "esophageal cancer EGFR 67-year-old male", "response": "Best treatment options for esophageal cancer in an elderly male patient (67 years old)?", "metadata": {"model": "llama"}}
{"query-id": "30", "query-text": "lung cancer ROS1 71-year-old female", "response": "Treatment options for lung cancer in elderly patients, specifically for those over 70.", "metadata": {"model": "llama"}}
{"query-id": "31", "query-text": "head and neck squamous cell carcinoma CDKN2A 64-year-old male", "response": "Treatment options for head and neck squamous cell carcinoma in a 64-year-old male", "metadata": {"model": "llama"}}
{"query-id": "32", "query-text": "leukemia ABL1 4-year-old female", "response": "Treatment options for 4-year-old female patient with Acute Lymphoblastic Leukemia (ALL)", "metadata": {"model": "llama"}}
{"query-id": "33", "query-text": "gastric cancer EGFR 60-year-old female", "response": "Cancer treatment options for gastric cancer in an 60-year-old female, specifically targeting EGFR.", "metadata": {"model": "llama"}}
{"query-id": "34", "query-text": "sarcoma MDM2 78-year-old female", "response": "MDM2 amplification in sarcoma, particularly in 78-year-old females.", "metadata": {"model": "llama"}}
{"query-id": "35", "query-text": "breast cancer CDKN2A 73-year-old female", "response": "CDKN2A mutation in breast cancer, what are the treatment options for a 73-year-old female patient?", "metadata": {"model": "llama"}}
{"query-id": "36", "query-text": "lung cancer ERBB2 49-year-old female", "response": "49-year-old female with lung cancer and ERBB2 status?", "metadata": {"model": "llama"}}
{"query-id": "37", "query-text": "non-small cell carcinoma MET 68-year-old male", "response": "Non-small cell carcinoma treatment options for a 68-year-old male.", "metadata": {"model": "llama"}}
{"query-id": "38", "query-text": "cholangiocarcinoma IDH1 50-year-old male", "response": "What are the treatment options for cholangiocarcinoma in a 50-year-old male?", "metadata": {"model": "llama"}}
{"query-id": "39", "query-text": "anaplastic large cell lymphoma ALK 18-year-old male", "response": "Information on anaplastic large cell lymphoma (ALK) in children and young adults?", "metadata": {"model": "llama"}}
{"query-id": "40", "query-text": "breast cancer ERBB2 56-year-old female", "response": "Best treatment options for untreated breast cancer ERBB2 positive 56-year-old female?", "metadata": {"model": "llama"}}
{"query-id": "41", "query-text": "papillary thyroid carcinoma NTRK1 46-year-old female", "response": "Information on NTRK1 mutation in papillary thyroid carcinoma, including prognosis and treatment options for a 46-year-old female patient.", "metadata": {"model": "llama"}}
{"query-id": "42", "query-text": "glioblastoma CDK6 84-year-old male", "response": "Targeted therapies for glioblastoma in elderly patients", "metadata": {"model": "llama"}}
{"query-id": "43", "query-text": "basal cell carcinoma PTCH1 56-year-old female", "response": "Treatment for basal cell carcinoma in a 56-year-old female", "metadata": {"model": "llama"}}
{"query-id": "44", "query-text": "glioma BRAF 82-year-old male", "response": "BRAF mutation in glioma [82-year-old male]", "metadata": {"model": "llama"}}
{"query-id": "45", "query-text": "thyroid cancer BRAF 40-year-old female", "response": "Best treatment options for thyroid cancer - BRAF mutation in 40-year-old female.", "metadata": {"model": "llama"}}
{"query-id": "46", "query-text": "lung cancer FGFR1 57-year-old male", "response": "FGFR1 gene mutation and lung cancer in elderly men.", "metadata": {"model": "llama"}}
{"query-id": "47", "query-text": "prostate cancer PTEN 70-year-old male", "response": "Best treatment options for prostate cancer in elderly patients (70 years old)?", "metadata": {"model": "llama"}}
{"query-id": "48", "query-text": "adenoid cystic carcinoma KIT 58-year-old female", "response": "How is KIT mutation associated with adenoid cystic carcinoma in a 58-year-old female?", "metadata": {"model": "llama"}}
{"query-id": "49", "query-text": "acute myeloid leukemia IDH1 1-year-old male", "response": "Treatment options for acute myeloid leukemia in children.", "metadata": {"model": "llama"}}
{"query-id": "50", "query-text": "acute myeloid leukemia FLT3 13-year-old male", "response": "FLT3 mutation and acute myeloid leukemia in children", "metadata": {"model": "llama"}}
